The Rosalind Franklin Institute (the Franklin), a company that develops new technologies to support life sciences and healthcare research, announced a new collaboration with MSD (tradename of Merck & Co., Inc., Rahway, N.J., USA) to look at cell regulation and how malfunctioning of specific cell regulation processes are implicated in neurodegenerative conditions, such as Parkinson’s disease. This collaboration will leverage the Franklin’s unique instrumentation and expertise in cryo electron tomography (cryoET) – a technique by which a molecular CT scan is taken of the inside of cells to reconstruct 3D images at nanometer scale.